Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial.
Del Campo, Josep M
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 11 2019 - 2968-2973 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1527-7755
10.1200/JCO.18.02238 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Double-Blind Method
Female
Humans
Indazoles--administration & dosage
Maintenance Chemotherapy
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Organoplatinum Compounds--administration & dosage
Ovarian Neoplasms--drug therapy
Piperidines--administration & dosage
Poly(ADP-ribose) Polymerase Inhibitors--administration & dosage
Progression-Free Survival
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 11 2019 - 2968-2973 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1527-7755
10.1200/JCO.18.02238 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Double-Blind Method
Female
Humans
Indazoles--administration & dosage
Maintenance Chemotherapy
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Organoplatinum Compounds--administration & dosage
Ovarian Neoplasms--drug therapy
Piperidines--administration & dosage
Poly(ADP-ribose) Polymerase Inhibitors--administration & dosage
Progression-Free Survival